Age-corrected hearing loss after chemoradiation in cervical cancer patients
ConclusionChemoradiation with cumulative cisplatin doses up to 400 mg did not lead to significant impairment of objective or subjective hearing. For cervical cancer patients undergoing chemoradiation, standard audiometry is not indicated.
Source: Strahlentherapie und Onkologie - Category: Cancer & Oncology Source Type: research
More News: Audiometry | Cancer | Cancer & Oncology | Cervical Cancer | Chemotherapy | Smokers | Statistics | Study